Dataset from A Phase II, Open-Label Co-Administration Study of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)

NIAID Data Ecosystem2026-05-02 收录

ADHD联合用药试验

儿童青少年临床研究

数据链接：

https://doi.org/10.25934/PR00010506 数据链接链接失效反馈

官方服务：

资源简介：

The purpose of this study is to assess the safety and tolerability of administering SPD503 (Guanfacine hydrochloride) with psychostimulants (amphetamine or methylphenidate) for treatment of ADHD in children and adolescents aged 6-17

创建时间：

2025-02-10

Dataset from A Phase II, Open-Label Co-Administration Study of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)

资源简介：

相关数据集